NCT00193388View on ClinicalTrials.gov

Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

February 28, 2007

Conditions

Lung Cancer

Interventions

DRUG

Topotecan

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER